ImmuCell Corporation Cash and Cash Equivalents, Fair Value Disclosure
ImmuCell Corporation (ICCC) had Cash and Cash Equivalents, Fair Value Disclosure of $8.86 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $8.86M.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $6.81M.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $3.81M.
- 2023-09-30: Cash and Cash Equivalents, Fair Value Disclosure $1.99M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure | Cash and Cash Equivalents, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $8.86M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $6.81M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.81M 10-Q · filed 2026-08-13 | |
| 2023-09-30 | $1.99M 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $3.10M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.79M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $8.83M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $11.04M 10-Q/A · filed 2022-11-21 | |
| 2022-03-31 | $11.82M 10-Q/A · filed 2022-11-21 | |
| 2021-12-31 | $10.19M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $10.50M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $10.70M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.81M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $6.95M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $3.92M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $6.20M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $6.51M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $6.29M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $2.35M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.30M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $10.58M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $2.52M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $2.39M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $2.51M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $3.06M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $3.80M 10-K · filed 2019-03-22 | $3.80M 10-K · filed 2018-03-29 |
| 2016-12-31 | $10.59M 10-K · filed 2018-03-29 | |
| 2015-12-31 | $6.46M 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |